Cargando…
Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma
OBJECTIVE: Fibroblast growth factor receptor gene alterations have emerged as promising drug targets for intrahepatic cholangiocarcinoma, a rare cancer that has a poor prognosis. This study evaluated the frequency of fibroblast growth factor receptor 2 fusions in clinical specimens from Japanese pat...
Autores principales: | Tsujie, Masanori, Iwai, Tomohisa, Kubo, Shoji, Ura, Takashi, Hatano, Etsuro, Sakai, Daisuke, Takeda, Yutaka, Kaibori, Masaki, Kobayashi, Tomoe, Katanuma, Akio, Katayose, Yu, Fukase, Koji, Sakurai, Naoki, Ito, Yukiko, Sato, Fumiya, Maeda, Atsuyuki, Asada, Masanori, Morizane, Chigusa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448429/ https://www.ncbi.nlm.nih.gov/pubmed/33822966 http://dx.doi.org/10.1093/jjco/hyab029 |
Ejemplares similares
-
Erratum to: Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma
por: Tsujie, Masanori, et al.
Publicado: (2021) -
Intrahepatic Cholangiocarcinoma: State of the Art of FGFR Inhibitors
por: Wu, Tianyu, et al.
Publicado: (2021) -
Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas
por: Pu, Xiaohong, et al.
Publicado: (2023) -
Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas
por: Pu, Xiaohong, et al.
Publicado: (2021) -
A Robust FISH Assay to Detect FGFR2 Translocations in Intrahepatic Cholangiocarcinoma Patients
por: Zhang, Lei, et al.
Publicado: (2023)